NCLT adjourns Lyka Labs amalgamation hearing to 19 Feb 2026

Regulatory & Legal View source PDF Explain this filing

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.1%Reaction day

₹69.10

prior close

₹72.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+3.7%-1.6% vs market

Pharmaceuticals peers, median of 157sector+2.6%-0.5% vs sector

On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.8

10m

-1.8

15m

-2.3

30m

-1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.1+3.7-1.6+2.6-0.5

Next day

+5.1+5.1-0.0+2.5+2.6

+3.3+4.0-0.8+1.6+1.7

+2.3+3.2-0.9+1.1+1.2

+2.0+5.9-3.9+2.9-0.9

+5.6+6.9-1.3+3.1+2.6

+1.7+5.9-4.2+2.6-0.9

15d

-11.7+2.1-13.8-0.6-11.1

-11.7-3.5-8.3-2.6-9.2

-21.2-4.2-17.0-4.7-16.5

-13.3+10.9-24.2+4.2-17.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lyka Labs informed exchanges that the NCLT Ahmedabad Bench heard the scheme of amalgamation between Lyka Exports and Lyka Labs on 29 January 2026. The applicant counsel confirmed compliance with the earlier order and filed an affidavit on FEMA compliance. The tribunal has taken the application and affidavit up for examination and listed the next hearing for 19 February 2026. No order on the merger has been passed yet.

Likely market impact

Procedural update only; no decision yet. Watch the 19 Feb 2026 hearing for any ruling on the amalgamation scheme.